Efficacy of once-weekly tirzepatide versus once-daily insulin degludec on glycaemic control measured by continuous glucose monitoring in adults with type 2 diabetes (SURPASS-3 CGM): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial
出版年份 2022 全文链接
标题
Efficacy of once-weekly tirzepatide versus once-daily insulin degludec on glycaemic control measured by continuous glucose monitoring in adults with type 2 diabetes (SURPASS-3 CGM): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial
作者
关键词
-
出版物
Lancet Diabetes & Endocrinology
Volume 10, Issue 6, Pages 407-417
出版商
Elsevier BV
发表日期
2022-04-23
DOI
10.1016/s2213-8587(22)00077-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial
- (2022) Amalia Gastaldelli et al. Lancet Diabetes & Endocrinology
- Accuracy of Dexcom G6 Continuous Glucose Monitoring in Non–Critically Ill Hospitalized Patients With Diabetes
- (2021) Georgia M. Davis et al. DIABETES CARE
- Association of HbA1c With All-cause Mortality Across Varying Degrees of Glycemic Variability in Type 2 Diabetes
- (2021) Jingyi Lu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial
- (2021) Bernhard Ludvik et al. LANCET
- Time in range: a new parameter to evaluate blood glucose control in patients with diabetes
- (2020) Monica Andrade Lima Gabbay et al. Diabetology & Metabolic Syndrome
- Glycemic variability – the danger of a physiologically stable metric
- (2020) Tadej Battelino et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Empagliflozin reduced long-term HbA1c variability and cardiovascular death: insights from the EMPA-REG OUTCOME trial
- (2020) Antonio Ceriello et al. Cardiovascular Diabetology
- Time in Range in Relation to All-Cause and Cardiovascular Mortality in Patients With Type 2 Diabetes: A Prospective Cohort Study
- (2020) Jingyi Lu et al. DIABETES CARE
- Fasting Glucose Variation Predicts Microvascular Risk in ACCORD and VADT
- (2020) Jin J Zhou et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
- (2019) Tadej Battelino et al. DIABETES CARE
- Optimal Sampling Duration for Continuous Glucose Monitoring to Determine Long-Term Glycemic Control
- (2018) Tonya D. Riddlesworth et al. Diabetes Technology & Therapeutics
- Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials
- (2018) Roy W. Beck et al. DIABETES CARE
- Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial
- (2018) Juan Pablo Frias et al. LANCET
- LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept
- (2018) Tamer Coskun et al. Molecular Metabolism
- Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report: Table 1
- (2016) David M. Maahs et al. DIABETES CARE
- Exenatide once weekly improved 24-hour glucose control and reduced glycaemic variability in metformin-treated participants with type 2 diabetes: a randomized, placebo-controlled trial
- (2016) Juan P. Frías et al. DIABETES OBESITY & METABOLISM
- Continuous glucose monitoring in patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonist dulaglutide in combination with prandial insulin lispro: an AWARD-4 substudy
- (2016) Johan Jendle et al. DIABETES OBESITY & METABOLISM
- Longitudinal tobit regression: A new approach to analyze outcome variables with floor or ceiling effects
- (2009) Jos Twisk et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Should baseline be a covariate or dependent variable in analyses of change from baseline in clinical trials?
- (2009) Guanghan F. Liu et al. STATISTICS IN MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started